Flow cytometry:ALAL-NOS: Difference between revisions
From haematologyetc.co.uk
(Created page with "---- <div style="width: 200px"> {| class="wikitable" style="border-left:solid 5px green;border-right:solid 5px green;border-top:solid 5px black;border-bottom:solid 5px black; font-size:90%; color:navy" | colspan="1"''|Return to previous page'' |} </div> ---- Reserved for cases where a primitive haematopoietic malignancy is established but where confident assignment to any specific category is not possible. This diagnosis is rar...") |
(No difference)
|
Latest revision as of 15:11, 31 December 2023
Reserved for cases where a primitive haematopoietic malignancy is established but where confident assignment to any specific category is not possible.
This diagnosis is rarely indcated as a final classification since almost all cases can be ascribed to an existing group. However, as a provisional diagnosis the term can have some value in cases where additional immunohistochemistry or molecular test results are awaited that might provide further diagnostic certainty.